During the corresponding time, Livento Group Inc recorded a revenue increase by 22.68 % year on year, sequentially revenue grew by 130.18 %. While revenue at the Livento Group Inc 's corporate clients
Livento Group Inc's Comment on Sales, Marketing and Customers
The company initially sold the GIAA Line through medical offices and GIAA, a related party, but discontinued it in 2008. From 2009 to 2010, sales were primarily overseas and limited to remaining GIAA inventory. In 2011, the company developed the NuGene Line, a proprietary cosmeceutical skincare line based on adult adipose human stem cells, customized for specific clients. The NuGene Line was manufactured in a leased laboratory facility affiliated with one of the founders. In 2013, stem cell services were provided to one client, an affiliated entity. By the end of 2014, approximately 50 locations, including medical offices and medical spas across the United States, distributed NuGene products. Additionally, revenues were generated from Advanced Surgical Partners (ASP), an affiliate owned by the CEO and Chairman, through providing Plasma Rich Platelet and Stem Cell injections for orthopedic and plastic surgery procedures during the transition to commercializing cosmeceutical products.
Livento Group Inc’s Comment on Sales, Marketing and Customers
The company initially sold the GIAA Line through medical offices and GIAA, a related party, but discontinued it in 2008. From 2009 to 2010, sales were primarily overseas and limited to remaining GIAA inventory. In 2011, the company developed the NuGene Line, a proprietary cosmeceutical skincare line based on adult adipose human stem cells, customized for specific clients. The NuGene Line was manufactured in a leased laboratory facility affiliated with one of the founders. In 2013, stem cell services were provided to one client, an affiliated entity. By the end of 2014, approximately 50 locations, including medical offices and medical spas across the United States, distributed NuGene products. Additionally, revenues were generated from Advanced Surgical Partners (ASP), an affiliate owned by the CEO and Chairman, through providing Plasma Rich Platelet and Stem Cell injections for orthopedic and plastic surgery procedures during the transition to commercializing cosmeceutical products.
Sources:
Livento Group Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Livento Group Inc’s corporate clients.
For your research, we’ve provided 9 tables on Livento Group Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
143.55 %